Evidence map›Paper›PMID 41543583›Full record

SynthesisArchives of gynecology and obstetrics2026

Non-invasive blood pressure monitoring using wearables for cardiovascular risk assessment: a systematic review.

Michelle Zwahlen, Elena Pavicic, Kerstin Khattab, Valerija Krbanjevic, Julia Endrass, Petra Stute

Abstract readSystematic Review
In one paragraph

Synthesis in Archives of gynecology and obstetrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Michelle ZwahlenFaculty of Medicine, University of Bern, Bern, Switzerland.
Elena PavicicDepartment of Obstetrics and Gynaecology, University Hospital of Bern, Bern, Switzerland.
Kerstin KhattabCardiance Clinic, Pfäffikon, Switzerland.
Valerija KrbanjevicFaculty of Medicine, University of Bern, Bern, Switzerland.
Julia EndrassFaculty of Medicine, University of Bern, Bern, Switzerland.
Petra StuteDepartment of Obstetrics and Gynaecology, University Hospital of Bern, Bern, Switzerland. petra.stute@insel.ch.ORCID 0000-0002-5591-1552

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCardiovascular diseases are the leading causes of mortality in women worldwide, with hypertension being a major risk factor. While traditional blood pressure monitoring techniques rely on cuff-based measurements, wearable devices offer a promising alternative for continuous and non-invasive blood pressure tracking. This systematic review investigates the extent to which wearable blood pressure measurements can serve as surrogates for traditional sensors to be implemented in risk assessment tools in predicting cardiovascular risk in women.

methodsA systematic search was conducted in databases including MEDLINE, Embase, Cochrane Library, Web of Science, Scopus and ClinicalTrials.gov. Studies published between 2010 and 2024 were included. Exclusion criteria were case reports or animal studies. Study selection was performed based on PRISMA guidelines. Data extraction focused on wearable devices, measurement approach, validation against gold-standard BP methods, and their predictive utility for cardiovascular outcomes.

resultsThe systematic literature search revealed 14'863 results after removal of duplicates, of which 245 were selected for extraction. Most included studies used photoplethysmography, with pulse transit time and pulse wave velocity as core parameters, some using machine learning. Accuracy was moderate to high for diastolic blood pressure, but systolic blood pressure showed greater variability. Cardiovascular risk stratification showed promising results, though external validation was rare.

conclusionWearable blood pressure monitoring technologies are maturing, with growing potential in preventive cardiovascular medicine in women. However, clinical implementation is limited by varying accuracy, need for calibration, and the lack of standardization. Further validation and longitudinal studies are needed to establish their role in cardiovascular risk prediction.

Indexed as

Blood Pressure DeterminationBlood Pressure Monitoring, AmbulatoryCardiovascular DiseasesWearable Electronic DevicesBlood PressureFemaleHumansPulse Wave AnalysisRisk AssessmentBlood pressureCardiovascular diseaseCardiovascular riskHealth monitoringHypertensionWearable devices

Identifiers

PMID41543583
PMCPMC12811358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.